While the 340B Program is essential for participating covered entities (CEs), it has presented providers with challenges pre-COVID, at the height of the pandemic, and today. Many CEs face concerns surrounding continued eligibility and program maintenance, while others actively seek expansion strategies to assist with offsetting costly pandemic impacts. During this webinar, PYA Consulting Senior Manager Sarah Bowman and Manager Katie Garmon discussed some of the latest actions. Topics included:
- Impact of new legislation.
- Child site expansion.
- Provider-based considerations.
- Contract pharmacy drug restrictions.
- Key auditing and monitoring elements.
- Recent case study.
The webinar took place on April 6, 2022.
Resources: SLIDES
This webinar was part of PYA’s twice-monthly “Healthcare Regulatory Roundup” series in which experts from across the firm provide practical insights on the latest regulatory developments.
FFor more information about our rural health expertise, please visit PYA’s Center for Rural Health Advancement. If you would like assistance with 340B Program eligibility, maintenance, or expansion strategies, or with any matter involving compliance, valuation, or strategy and transactions, one of our executive contacts would be happy to assist. You may email them below, or call (800) 270-9629. You can also visit PYA’s COVID-19 hub.
